This session’s featured segments include:
- In the Spotlight: Reviewing Your Summary Plan Descriptions: The Who, What, When, Why, and How
A brief overview of summary plan descriptions, including what material they should contain and how it should be organized, who should receive them and what distribution methods are allowed, when and under what circumstances they need to be provided, and the consequences of making mistakes. - HRAs and FSAs: An Update on the Current Legal Requirements
Over the past year and a half, the IRS has issued guidance about HRAs and FSAs, including the recently permitted $500 carryover rule. We will discuss the current state of the law so that you can ensure your medical reimbursement account plans are in compliance with legal requirements. - Year-End Amendments
This segment will discuss all the retirement and health and welfare amendments that are required to be signed before December 31, 2014.
Speakers
- Leigh C. Riley, Partner, Foley & Lardner LLP
- Katherine L. Aizawa, Special Counsel, Foley & Lardner LLP
- Isaac J. Morris, Senior Counsel, Foley & Lardner LLP
People
Related Insights
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Health Care Law Today
FDA Continues to Take Stance That it Will Not Issue CBD Rules
The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.